Effect Of A Non-Steroidal Aromatase Inhibitor On Ovarian Function And Synchronicity Of Estrus In Ewes At Subtropics

Effects of non-steroidal aromatase inhibitor letrozole on ovarian function in ewe were investigated through testing the hypothesis that letrozole will arrest the growth of dominant follicles, resulting in the emergence of a new follicular wave at a predictable post-treatment interval. Treatment ewes (n = 10) were treated using an intravaginal sponge (regardless of the stage of estrus) containing 7.5 mg letrozole for five days followed by prostaglandin injection. The control group (n = 10) was treated with gonadotropin prostaglandin gonadotropin (GPG) protocol for ovarian synchronization. Ovarian structures were daily monitored with trans rectal ultrasonography concomitant with blood sampling. Commercial enzyme-linked immunosorbent assay Kits assigned steroid concentration of estradiol, testosterone and progesterone. Some biochemical parameters including blood glucose, total proteins, lipid profiles were measured as a preliminary screening for the effect of applied letrozole treatment on ewes general health condition. Treatment with letrozole decreased serum concentrations of estradiol during sponge insert in the vagina while its concentration increased following removal correlated with the number of ovulatory follicles. On the other hand, the concentration of  Progesterone increased correlated with increased number and diameter of corpora lutea resulting from increased diameter and number of ovulatory follicles. The onset of estrus was about 54.00 ± 0.40 hrs. After sponge removal and continued for 25.17 ±  0.24 hrs. Ovulation was synchronous and occurred at 78.70 ±  0.21 hrs after sponge removal. There was no effect of letrozole treatment on measured metabolic parameters. We concluded that letrozole proved to have potential as a non-steroidal treatment for controlling ovarian function and onset of estrus in the ewe.

[1]  R. Pierson,et al.  Aromatase inhibitors: A new approach for controlling ovarian function in cattle. , 2017, Theriogenology.

[2]  R. Pierson,et al.  Synchronization of ovulation in cattle with an aromatase inhibitor-based protocol. , 2016, Theriogenology.

[3]  P. Papa,et al.  Equine chorionic gonadotropin alters luteal cell morphologic features related to progesterone synthesis. , 2013, Theriogenology.

[4]  R. Casper,et al.  A historical perspective of aromatase inhibitors for ovulation induction. , 2012, Fertility and sterility.

[5]  J. Giesy,et al.  Effects of a non-steroidal aromatase inhibitor on ovarian function in cattle. , 2012, Reproduction, fertility, and development.

[6]  R. Pierson,et al.  176 EFFECTS OF VEHICLE AND ROUTE OF ADMINISTRATION OF LETROZOLE ON OVARIAN FUNCTION IN CATTLE , 2011 .

[7]  David J Brayden,et al.  Drug delivery systems in domestic animal species. , 2010, Handbook of experimental pharmacology.

[8]  C. Bell Clinical Guide to Laboratory Tests. 3rd edition. Norbert W. Tietz, ed. , 2009 .

[9]  M. Farré,et al.  Use of letrozole in assisted reproduction: a systematic review and meta-analysis , 2008, Human reproduction update.

[10]  R. Casper,et al.  Letrozole Step-Up Protocol: a Successful Superovulation Protocol , 2008 .

[11]  S. Kiran,et al.  Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. , 2006, Fertility and sterility.

[12]  E. Kolibianakis,et al.  Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. , 2006, Reproductive biomedicine online.

[13]  E. Perez,et al.  The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L). , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  R. Casper,et al.  Single-dose administration of an aromatase inhibitor for ovarian stimulation. , 2005, Fertility and sterility.

[15]  R. Casper,et al.  Aromatase inhibition for ovarian stimulation: future avenues for infertility management , 2002, Current opinion in obstetrics & gynecology.

[16]  W. Boon,et al.  Aromatase--a brief overview. , 2002, Annual review of physiology.

[17]  M. Schwerin,et al.  Expression of the aromatase cytochrome P450 encoding gene in cattle and sheep , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[18]  D. Ibarreta,et al.  Possible health impact of animal oestrogens in food , 2001, Human reproduction update.

[19]  P. Goss,et al.  Aromatase inhibitors in the treatment and prevention of breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A. Menchaca,et al.  Ovarian dynamics, serum estradiol and progesterone concentrations during the interovulatory interval in goats. , 1999, Theriogenology.

[21]  N. Skakkebaek,et al.  Exposure to exogenous estrogens in food: possible impact on human development and health. , 1999, European journal of endocrinology.

[22]  D. Valbuena,et al.  Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. , 1995, Human reproduction.

[23]  R. Leng Factors Affecting the Utilization of ‘Poor-Quality’ Forages by Ruminants Particularly Under Tropical Conditions , 1990, Nutrition Research Reviews.

[24]  H. Alila,et al.  Origin of different cell types in the bovine corpus luteum as characterized by specific monoclonal antibodies. , 1984, Biology of reproduction.

[25]  D. Chou Clinical Guide to Laboratory Tests , 1984 .

[26]  Wesley G. Kaldahl Factors Affecting Utilization , 1966 .